This invention is directed to a compound of Formula (I):
and pharmaceutically acceptable forms thereof useful as inhibitors of cPLA
2
and a method for preventing, treating or ameliorating a cPLA
2
mediated inflammatory related disease, disorder or condition using a compound of Formula (I) and, more particularly, for preventing, treating or ameliorating a cPLA
2
mediated inflammatory related disease, disorder or condition which results from the cellular secretion of TXB
2
or LTB
4
.
这项发明涉及一种化合物,其
化学式为(I):
及其药学上可接受的形式,用作cP
LA
2
的
抑制剂,以及使用化合物(I)预防、治疗或改善由cP
LA
2
介导的炎症相关疾病、紊乱或状况的方法,更具体地说,用于预防、治疗或改善由细胞分泌TXB
2
或LTB
4
引起的cP
LA
2
介导的炎症相关疾病、紊乱或状况。